[October 05, 2015]

Research and Markets: Gastric Cancer - Pipeline Review, H2 2015 Featuring Over 100 Companies

Research and Markets (http://www.researchandmarkets.com/research/5zsb5g/gastric_cancer) has announced the addition of the "Gastric Cancer - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Gastric Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastric Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and helps to create effective counter srategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned - 30 of the 100+ Companies

• AB Science SA
• AbbVie Inc.
• AbGenomics International, Inc.
• Advaxis, Inc.
• Advenchen Laboratories, LLC
• AlphaVax, Inc.
• Ambrx, Inc.
• Amgen Inc.
• Aslan Pharmaceuticals Pte. Ltd.
• Astellas Pharma Inc.
• AstraZeneca Plc
• AVEO Pharmaceuticals, Inc.
• Azaya Therapeutics Incorporated
• Basilea Pharmaceutica AG
• Bayer AG
• BioMarin Pharmaceutical Inc.
• Biotecnol, Inc.
• Boehringer Ingelheim GmbH
• Boston Biomedical, Inc.
• Bristol-Myers Squibb Company
• cCAM Biotherapeutics Ltd.
• Celgene Corporation
• Celldex Therapeutics, Inc.
• Cellectar Biosciences, Inc.
• Celltrion, Inc.
• Celon Pharma Sp. z o.o.
• Cerulean Pharma, Inc.
• Chipscreen Biosciences Ltd
• Chugai Pharmaceutical Co., Ltd.
• Curaxys, S.L.
  

For more information visit http://www.researchandmarkets.com/research/5zsb5g/gastric_cancer

View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005770/en/

[ Back To TMCnet.com's Homepage ]